Lineage Cell Therapeutics
LCTX
#8691
Rank
โ‚น10.48 B
Marketcap
โ‚น47.59
Share price
11.16%
Change (1 day)
-47.00%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -โ‚น10.67

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น11.09. In 2022 the company made an earnings per share (EPS) of -โ‚น12.79 an increase over its 2021 EPS that were of -โ‚น22.17.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น10.67-16.61%
2022-โ‚น12.79-42.31%
2021-โ‚น22.1785.71%
2020-โ‚น11.94250%
2019-โ‚น3.41-88.57%
2018-โ‚น29.85105.88%
2017-โ‚น14.50-153.13%
2016โ‚น27.29-154.24%
2015-โ‚น50.315.36%
2014-โ‚น47.76-30.86%
2013-โ‚น69.0888.37%
2012-โ‚น36.6719.44%
2011-โ‚น30.7033.33%
2010-โ‚น23.0368.75%
2009-โ‚น13.64-5.88%
2008-โ‚น14.50183.33%
2007-โ‚น5.12-25%
2006-โ‚น6.82-27.27%
2005-โ‚น9.38-38.89%
2004-โ‚น15.3538.46%
2003-โ‚น11.09-43.48%
2002-โ‚น19.61-26.63%
2001-โ‚น26.73-28.75%
2000-โ‚น37.52-13.73%
1999-โ‚น43.49
1997-โ‚น28.143.13%
1996-โ‚น27.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น185.91 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA